Divergences in antihypertensive therapy in special situations in nephrology

CONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-...

Full description

Bibliographic Details
Main Authors: Marcelo Montebello Lemos, Alessandra Coelho Pedrosa, Alze Pereira Tavares, Miguel Ângelo Góes, Sérgio Antônio Draibe, Ricardo Sesso
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007&lng=en&tlng=en
id doaj-23e710b7986340a8bc096216bd2377bd
record_format Article
spelling doaj-23e710b7986340a8bc096216bd2377bd2020-11-25T01:51:51ZengAssociação Paulista de MedicinaSão Paulo Medical Journal1806-94601261344010.1590/S1516-31802008000100007S1516-31802008000100007Divergences in antihypertensive therapy in special situations in nephrologyMarcelo Montebello Lemos0Alessandra Coelho Pedrosa1Alze Pereira Tavares2Miguel Ângelo Góes3Sérgio Antônio Draibe4Ricardo Sesso5Universidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloUniversidade Federal de São PauloCONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007&lng=en&tlng=enHypertensionAntihypertensive agentsKidney diseasesGuidelinesEvidence-based medicine
collection DOAJ
language English
format Article
sources DOAJ
author Marcelo Montebello Lemos
Alessandra Coelho Pedrosa
Alze Pereira Tavares
Miguel Ângelo Góes
Sérgio Antônio Draibe
Ricardo Sesso
spellingShingle Marcelo Montebello Lemos
Alessandra Coelho Pedrosa
Alze Pereira Tavares
Miguel Ângelo Góes
Sérgio Antônio Draibe
Ricardo Sesso
Divergences in antihypertensive therapy in special situations in nephrology
São Paulo Medical Journal
Hypertension
Antihypertensive agents
Kidney diseases
Guidelines
Evidence-based medicine
author_facet Marcelo Montebello Lemos
Alessandra Coelho Pedrosa
Alze Pereira Tavares
Miguel Ângelo Góes
Sérgio Antônio Draibe
Ricardo Sesso
author_sort Marcelo Montebello Lemos
title Divergences in antihypertensive therapy in special situations in nephrology
title_short Divergences in antihypertensive therapy in special situations in nephrology
title_full Divergences in antihypertensive therapy in special situations in nephrology
title_fullStr Divergences in antihypertensive therapy in special situations in nephrology
title_full_unstemmed Divergences in antihypertensive therapy in special situations in nephrology
title_sort divergences in antihypertensive therapy in special situations in nephrology
publisher Associação Paulista de Medicina
series São Paulo Medical Journal
issn 1806-9460
description CONTEXT AND OBJECTIVE: The choice of an antihypertensive drug is based on several criteria and specific situations give rise to doubt and controversy. The aim here was to evaluate physicians’ approaches towards treatment with antihypertensive agents in specific situations. DESIGN AND SETTING: Cross-sectional study, at Universidade Federal de São Paulo, São Paulo. METHODS: A questionnaire was applied during a nephrology meeting to evaluate individual approaches towards each hypothetical clinical situation. The questionnaire consisted of five multiple-choice questions (clinical cases) concerning controversial aspects of antihypertensive therapy. RESULTS: A total of 165 questionnaires were analyzed. Most participants were nephrologists (93.2%). There was a preference for angiotensin-converting enzyme (ACE) inhibitors in at least two of the cases. Only 57.2% of the physicians were correct in choosing beta-blockers as the first-line drugs for patients with ischemic coronary disease. Moreover, 66.2% chose ACE inhibitors as the first-line drugs for patients with chronic kidney disease and proteinuria. About 5% of the physicians did not follow the current recommendations for the use of ACE inhibitors in diabetic patients with microalbuminuria. The most controversial question concerned the first-line drug for advanced chronic kidney disease. Most physicians were correct in choosing calcium channel blockers and avoiding ACE inhibitors in renovascular hypertension in the case of a patient with a single functioning kidney. CONCLUSIONS: Most physicians adopted the correct approach, but some had an alternative strategy for the same situations that was not based on evidence.
topic Hypertension
Antihypertensive agents
Kidney diseases
Guidelines
Evidence-based medicine
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802008000100007&lng=en&tlng=en
work_keys_str_mv AT marcelomontebellolemos divergencesinantihypertensivetherapyinspecialsituationsinnephrology
AT alessandracoelhopedrosa divergencesinantihypertensivetherapyinspecialsituationsinnephrology
AT alzepereiratavares divergencesinantihypertensivetherapyinspecialsituationsinnephrology
AT miguelangelogoes divergencesinantihypertensivetherapyinspecialsituationsinnephrology
AT sergioantoniodraibe divergencesinantihypertensivetherapyinspecialsituationsinnephrology
AT ricardosesso divergencesinantihypertensivetherapyinspecialsituationsinnephrology
_version_ 1724995998897405952